Intravenous labetalol versus oral nifedipine for acute blood pressure control in severe pre-eclampsia and eclampsia: A prospective randomized comparative study

Read full text Summarise with VIRAT
Authors: Sanjula Gayathri R, Girija MK
Cited by: 0
References: 29

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Hypertensive disorders of pregnancy are among the leading causes of maternal and perinatal mortality worldwide, contributing to nearly one-tenth of maternal deaths in Asia and Africa [1, 2]. Acute severe hypertension in pregnancy, defined as a sustained systolic blood pressure ?160 mmHg or diastolic blood pressure ?110 mmHg, requires prompt pharmacological intervention to prevent serious maternal complications including stroke, eclampsia, and end-organ damage [3, 4]. This study aimed to compare intravenous (IV) labetalol and oral nifedipine in terms of efficacy, time to target blood pressure, number of doses required, safety profile, adverse drug reactions, and maternal and fetal outcomes in severe pre-eclampsia and eclampsia.Methods: A prospective randomized comparative study was conducted in 60 patients with severe pre-eclampsia or eclampsia at Dr. B.R. Ambedkar Medical College and Hospital, Bangalore, from August 2019 to July 2021. Patients were randomized (n=30 per group) to receive IV labetalol (escalating doses of 20, 40, 80, 80, 80 mg) or oral nifedipine (10 mg up to 5 doses) every 15 minutes until target blood pressure of 150/90 mmHg was achieved.Results: The mean time to achieve target blood pressure was 33.5±11.61 minutes with labetalol and 29±10.37 minutes with nifedipine (p=0.119). No significant difference was observed in the number of doses required (p=0.329), systolic blood pressure reduction (p>0.05 at all-time intervals), or adverse drug reactions (p=0.065). Both drugs achieved blood pressure control in all 60 patients with no crossover required.Conclusion: Both IV labetalol and oral nifedipine are equally efficacious and safe for acute blood pressure control in hypertensive emergencies of pregnancy. Oral nifedipine may be preferred in low-resource settings due to its simpler administration, lower cost, and oral route.

Fields of Study & Subjects

Pregnancy and preeclampsia studies Neurological Complications and Syndromes Blood Pressure and Hypertension Studies

Publication details

Journal / source
International Journal of Clinical Obstetrics and Gynaecology
Volume
10
Issue
2
Pages
547–554
Publication date
1 March 2026
Language
EN